Zacks Rating on Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX) : The consensus on Becton Dickinson and Company (BDX) based on 13 analyst recommendation on the company stock is 1.62, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 9 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Becton Dickinson and Company (BDX) : The highest short term price target forecast on Becton Dickinson and Company (BDX) is $200 and the lowest target price is $169. A total of 12 equity analysts are currently covering the company. The average price of all the analysts is $184.58 with a standard deviation of $9.4.


Shares of Becton, Dickinson and Company rose by 1.23% in the last five trading days and 1.23% for the last 4 weeks. Becton, Dickinson and Company is up 5.73% in the last 3-month period. Year-to-Date the stock performance stands at 14.46%. Becton Dickinson and Company (NYSE:BDX): stock turned positive on Tuesday. Though the stock opened at $174.75, the bulls momentum made the stock top out at $176 level for the day. The stock recorded a low of $174.71 and closed the trading day at $174.91, in the green by 0.26%. The total traded volume for the day was 688,449. The stock had closed at $174.46 in the previous days trading.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.